ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $224.72 million. The enterprise value is $194.70 million.

Market Cap	224.72M
Enterprise Value	194.70M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, after market close.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

ALXO has 134.56 million shares outstanding. The number of shares has increased by 2.84% in one year.

Current Share Class	134.56M
Shares Outstanding	134.56M
Shares Change (YoY)	+2.84%
Shares Change (QoQ)	+1.32%
Owned by Insiders (%)	1.23%
Owned by Institutions (%)	20.57%
Float	107.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.50
P/TBV Ratio	8.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.57.

Current Ratio	2.07
Quick Ratio	1.84
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-62.95

Financial Efficiency

Return on equity (ROE) is -145.70% and return on invested capital (ROIC) is -76.74%.

Return on Equity (ROE)	-145.70%
Return on Assets (ROA)	-60.95%
Return on Invested Capital (ROIC)	-76.74%
Return on Capital Employed (ROCE)	-292.37%
Weighted Average Cost of Capital (WACC)	7.12%
Revenue Per Employee	n/a
Profits Per Employee	-$2.37M
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +187.93% in the last 52 weeks. The beta is 0.50, so ALXO's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+187.93%
50-Day Moving Average	2.04
200-Day Moving Average	1.48
Relative Strength Index (RSI)	40.66
Average Volume (20 Days)	1,195,432

Short Selling Information

The latest short interest is 2.05 million, so 1.52% of the outstanding shares have been sold short.

Short Interest	2.05M
Short Previous Month	2.22M
Short % of Shares Out	1.52%
Short % of Float	1.91%
Short Ratio (days to cover)	2.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-100.85M
Pretax Income	-101.70M
Net Income	-101.70M
EBITDA	-100.14M
EBIT	-100.85M
Earnings Per Share (EPS)	-$1.90

Balance Sheet

The company has $44.79 million in cash and $14.77 million in debt, with a net cash position of $30.02 million or $0.22 per share.

Cash & Cash Equivalents	44.79M
Total Debt	14.77M
Net Cash	30.02M
Net Cash Per Share	$0.22
Equity (Book Value)	25.98M
Book Value Per Share	0.48
Working Capital	26.17M

Cash Flow

In the last 12 months, operating cash flow was -$84.14 million and capital expenditures -$212,000, giving a free cash flow of -$84.35 million.

Operating Cash Flow	-84.14M
Capital Expenditures	-212,000
Depreciation & Amortization	706,000
Net Borrowing	-1.36M
Free Cash Flow	-84.35M
FCF Per Share	-$0.63

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.84%
Shareholder Yield	-2.84%
Earnings Yield	-45.26%
FCF Yield	-37.54%

Analyst Forecast

The average price target for ALXO is $3.50, which is 109.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.50
Price Target Difference	109.58%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2